Atlas Trials

Effects of Inulin on Cardiometabolic Risk Factors in Individuals Using Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA ) Medications for Weight Loss

Clinical trial NCT07611552 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07611552
Sponsor
Huazhong University of Science and Technology
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Obesity & Overweight
Start date
2026-06-01
Primary completion
2026-11-01
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.